Biomarkers for Alzheimer’s Disease in the Current State: A Narrative Review - PMC
The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 1Ph.D. Program in Health Data Science, Faculty of Medicine, University of Porto, 4200-450 Porto, Portugal; moc.liamg@mcsorot 2Center for Minimally Invasive Therapies, Institute of Medical Science Research and Development, Tokyo Medical University, Tokyo 160-8402, Japan; moc.liamg@627imuyza (Y.A.); moc.liamg@1310.uohso (T.S.) 2Center for Minimally Invasive Therapies, Institute of Medical Science Research and Development, Tokyo Medical University, Tokyo 160-8402, Japan; moc.liamg@627imuyza (Y.A.); moc.liamg@1310.uohso (T.S.) 2Center for Minimally Inv
Int J Mol Sci . 2022 Apr 29;23(9):4962. doi: 10.3390/ijms23094962 Biomarkers for Alzheimer’s Disease in the Current State: A Narrative Review Serafettin Gunes Serafettin Gunes 1 Ph.D. Program in Health Data Science, Faculty of Medicine, University of Porto, 4200-450 Porto, Portugal; toroscm@gmail.com Find articles by Serafettin Gunes 1 , Yumi Aizawa Yumi Aizawa 2 Center for Minimally Invasive Therapies, Institute of Medical Science Research and Development, Tokyo Medical University, Tokyo 160-8402, Japan; azyumi726@gmail.com (Y.A.); oshou.0131@gmail.com (T.S.) Find articles by Yumi Aizawa 2 ,
Explore this link on the map →saved by
related reading
- Staging Dementia Using Clinical Dementia Rating Scale Sum of Boxes Scores: A Texas Alzheimer's Research Consortium Study - PMCncbi.nlm.nih.gov
- Using Interpretability to Identify a Novel Class of Alzheimer's Biomarkersgoodfire.ai
- Biomarkers of Neurodegenerative Diseases: Biology, Taxonomy, Clinical Relevance, and Current Research Status - PMCncbi.nlm.nih.gov
- Brain Imaging in Differential Diagnosis of Dementiapracticalneurology.com
- Biomarkers for Parkinson’s Disease: How Good Are They? - PMCpmc.ncbi.nlm.nih.gov
- Gap Mapgap-map.org
- Blood biomarkers in ALS: challenges, applications and novel frontiers - PMCncbi.nlm.nih.gov
- APOE4 homozygosity represents a distinct genetic form of Alzheimer’s disease | Nature Medicinenature.com
- Eye test can detect early Alzheimer'stherecord.com
- 'Breakthrough' blood test can find dementia risk before symptoms startnypost.com
- FDA Clears First Blood Test Used in Diagnosing Alzheimer’s Disease | FDAfda.gov
- AI for Alzheimer’sopenaifoundation.org